Cargando…
Risk factors associated with inflammatory bowel disease: A multicenter case-control study in Brazil
BACKGROUND: The etiology of inflammatory bowel disease (IBD) is unknown, but it is believed to be multifactorial. The hygiene hypothesis proposes that better hygiene conditions would lead to less infectious disease during childhood and favor the development of immune-mediated diseases. AIM: To test...
Autores principales: | Salgado, Valéria Cristina Loureiro, Luiz, Ronir Raggio, Boéchat, Neio Lucio Fernandes, Leão, Isabella Sued, Schorr, Bianca do Carmo, Parente, José Miguel Luz, Lima, Daniela Calado, Silveira Júnior, Eduardo Santos, Silva, Genoile Oliveira Santana, Almeida, Neogélia Pereira, Vieira, Andrea, de Bueno, Maria Luiza Queiroz, Chebli, Júlio Maria, Bertges, Érika Ruback, Brugnara, Luísa Martins da Costa, Junqueira Neto, Columbano, Campbell, Stefania Burjack Gabriel, Discacciati, Luana Letiza, Cézar, João Paulo Silva, Nunes, Tiago, Kaplan, Gilaad G, Zaltman, Cyrla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366056/ https://www.ncbi.nlm.nih.gov/pubmed/32742130 http://dx.doi.org/10.3748/wjg.v26.i25.3611 |
Ejemplares similares
-
Crohn’s disease environmental factors in the developing world: A case-control study in a statewide catchment area in Brazil
por: Salgado, Valéria Cristina Loureiro, et al.
Publicado: (2017) -
Hospitalization and surgery rates in patients with inflammatory bowel disease in Brazil: a time-trend analysis
por: Palacio, Flávia Gonçalves Musauer, et al.
Publicado: (2021) -
Pemphigus Vulgaris in the Mouth and Esophageal Mucosa
por: de Macedo, Angelo Gualberto, et al.
Publicado: (2018) -
Effectiveness and Safety of Ustekinumab for Moderate to Severely Active Crohn’s Disease: Results from an Early Access Program in Brazil
por: Chebli, Julio Maria Fonseca, et al.
Publicado: (2022) -
The optimal time to perform an ophthalmic examination of patients with inflammatory bowel disease
por: Biancardi, Ana Luiza, et al.
Publicado: (2019)